CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate-0.57-0.59-2.05-2.82
Low Estimate-0.7-0.7-2.29-3.33
High Estimate-0.51-0.48-1.9-2.35
Year Ago EPS-0.38-0.35-2.23-2.05
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate150k190k850kN/A
Low EstimateN/AN/A370kN/A
High Estimate550k550k1.47MN/A
Year Ago Sales548k781k2.43M850k
Sales Growth (year/est)-72.60%-75.70%-65.00%N/A
Earnings History2018-09-292018-12-302019-03-302019-06-29
EPS Est.-0.34-0.41-0.41-0.46
EPS Actual-0.38-0.35-0.37-0.51
Difference-0.040.060.04-0.05
Surprise %-11.80%14.60%9.80%-10.90%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.57-0.59-2.05-2.82
7 Days Ago-0.57-0.59-2.05-2.82
30 Days Ago-0.57-0.59-2.05-2.82
60 Days Ago-0.57-0.59-2.05-2.82
90 Days Ago-0.53-0.56-1.92-2.51
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCRNXIndustrySectorS&P 500
Current Qtr.-50.00%N/AN/A-0.02
Next Qtr.-68.60%N/AN/A0.07
Current Year8.10%N/AN/A-0.02
Next Year-37.60%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A